
Po-chih Chen
Examiner (ID: 15962, Phone: (571)270-7243 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1626 |
| Total Applications | 947 |
| Issued Applications | 619 |
| Pending Applications | 116 |
| Abandoned Applications | 237 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12217465
[patent_doc_number] => 20180055824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'SUBSTITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/804842
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18712
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15804842
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/804842 | Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections | Nov 5, 2017 | Issued |
Array
(
[id] => 15163145
[patent_doc_number] => 10487052
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Synthesis method of N-substituted maleimide using solid acid catalysts
[patent_app_type] => utility
[patent_app_number] => 16/091475
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4980
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091475
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091475 | Synthesis method of N-substituted maleimide using solid acid catalysts | Nov 5, 2017 | Issued |
Array
(
[id] => 16861673
[patent_doc_number] => 11020395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Cycloalkyl substituted triazole compounds as agonists of the APJ receptor
[patent_app_type] => utility
[patent_app_number] => 16/347942
[patent_app_country] => US
[patent_app_date] => 2017-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 60750
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 944
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347942 | Cycloalkyl substituted triazole compounds as agonists of the APJ receptor | Nov 2, 2017 | Issued |
Array
(
[id] => 13443953
[patent_doc_number] => 20180273519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/802850
[patent_app_country] => US
[patent_app_date] => 2017-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 452
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15802850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/802850 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | Nov 2, 2017 | Abandoned |
Array
(
[id] => 15527023
[patent_doc_number] => 20200055817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => SPIRO-COMPOUNDS AS SIP MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/346642
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346642
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346642 | SPIRO-COMPOUNDS AS SIP MODULATORS | Nov 1, 2017 | Abandoned |
Array
(
[id] => 16090157
[patent_doc_number] => 20200199065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => FUNCTIONAL DERIVATIVE COMPOUNDS OF ALANINE AND PROLINE AMINO ACIDS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 16/346028
[patent_app_country] => US
[patent_app_date] => 2017-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346028
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346028 | FUNCTIONAL DERIVATIVE COMPOUNDS OF ALANINE AND PROLINE AMINO ACIDS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Oct 29, 2017 | Pending |
Array
(
[id] => 15556697
[patent_doc_number] => 20200062760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/344061
[patent_app_country] => US
[patent_app_date] => 2017-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344061 | SHP2 phosphatase inhibitors and methods of use thereof | Oct 23, 2017 | Issued |
Array
(
[id] => 12158809
[patent_doc_number] => 20180030076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'Crystalline Fosaprepitant Dicyclohexylamine Salt and its Preparation'
[patent_app_type] => utility
[patent_app_number] => 15/728972
[patent_app_country] => US
[patent_app_date] => 2017-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4014
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15728972
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/728972 | Crystalline fosaprepitant dicyclohexylamine salt and its preparation | Oct 9, 2017 | Issued |
Array
(
[id] => 16222638
[patent_doc_number] => 20200247754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/341595
[patent_app_country] => US
[patent_app_date] => 2017-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341595
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341595 | Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use | Oct 8, 2017 | Issued |
Array
(
[id] => 13386283
[patent_doc_number] => 20180244683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => ANTIVIRAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/725193
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15725193
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/725193 | ANTIVIRAL COMPOUNDS | Oct 3, 2017 | Abandoned |
Array
(
[id] => 15740557
[patent_doc_number] => 20200109166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => POLYAMIDE COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/321430
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321430 | Polyamide compound and use thereof | Sep 21, 2017 | Issued |
Array
(
[id] => 12239815
[patent_doc_number] => 20180072677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'Peptidomimetics and Methods of Using the Same'
[patent_app_type] => utility
[patent_app_number] => 15/705497
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26021
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705497
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705497 | Peptidomimetics and methods of using the same | Sep 14, 2017 | Issued |
Array
(
[id] => 17207703
[patent_doc_number] => 11168062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Compounds for the treatment of
[patent_app_type] => utility
[patent_app_number] => 16/332311
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 12905
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332311 | Compounds for the treatment of | Sep 11, 2017 | Issued |
Array
(
[id] => 13717061
[patent_doc_number] => 20170369485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => HETEROCYCLIC INHIBITORS OF GLUTAMINASE
[patent_app_type] => utility
[patent_app_number] => 15/700796
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15700796
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/700796 | Heterocyclic inhibitors of glutaminase | Sep 10, 2017 | Issued |
Array
(
[id] => 14518937
[patent_doc_number] => 10336715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Phosphoric acid loaded covalent organic framework and a process for the preparation thereof
[patent_app_type] => utility
[patent_app_number] => 15/689419
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 32
[patent_no_of_words] => 3931
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15689419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/689419 | Phosphoric acid loaded covalent organic framework and a process for the preparation thereof | Aug 28, 2017 | Issued |
Array
(
[id] => 20824881
[patent_doc_number] => 12678423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-14
[patent_title] => Therapeutic agent for amyotrophic lateral sclerosis and composition for treatment
[patent_app_type] => utility
[patent_app_number] => 16/328636
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 3292
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328636
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328636 | Therapeutic agent for amyotrophic lateral sclerosis and composition for treatment | Aug 28, 2017 | Issued |
Array
(
[id] => 12624378
[patent_doc_number] => 20180099956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating
[patent_app_type] => utility
[patent_app_number] => 15/680477
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680477
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/680477 | Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating | Aug 17, 2017 | Abandoned |
Array
(
[id] => 12092508
[patent_doc_number] => 20170349600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'INDOLINE ANALOGS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/680905
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 19198
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/680905 | Indoline analogs and uses thereof | Aug 17, 2017 | Issued |
Array
(
[id] => 14467571
[patent_doc_number] => 20190185428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => METHOD FOR PRODUCING CHIRAL AMINONITRILES
[patent_app_type] => utility
[patent_app_number] => 16/328519
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328519 | METHOD FOR PRODUCING CHIRAL AMINONITRILES | Aug 16, 2017 | Abandoned |
Array
(
[id] => 12233071
[patent_doc_number] => 20180065932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'ANTIVIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/678901
[patent_app_country] => US
[patent_app_date] => 2017-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 139731
[patent_no_of_claims] => 152
[patent_no_of_ind_claims] => 107
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15678901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/678901 | ANTIVIRAL COMPOUNDS | Aug 15, 2017 | Abandoned |